Bladder cancer and immuno-oncology therapies

Bladder cancer and immuno-oncology therapies

Slides in the pack:

1. Pathology, symptoms and prevalence
2. Genetic basis, screening and complications
3. Causes, risk factors, diagnostic methods
4. General trends in bladder cancer (US)no
5. Epidemiology of bladder cancer
6. Timeline of advancements in bladder cancer treatment (1)
7. Timeline of advancements in bladder cancer treatment (2)
8. Overview of therapies for bladder cancer
9. Flowchart showing bladder cancer treatment options
10. Drugs and treatment costs of bladder cancer
11. Immunotherapies counter cancer-linked immunosuppression by re-initiating a self-sustaining immunity cycle, that has antitumor effects
12. Landscape of immuno-oncology therapies for bladder cancer (1)
13. Landscape of immuno-oncology therapies for bladder cancer (2)
14. Pipeline drugs that may emerge as competition to immuno-oncology therapies for bladder cancer
15. 2015 share of oncology medicines launched in 2010 – 2014